190 related articles for article (PubMed ID: 33359403)
21. Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids.
Villanueva CJ; Monetti M; Shih M; Zhou P; Watkins SM; Bhanot S; Farese RV
Hepatology; 2009 Aug; 50(2):434-42. PubMed ID: 19472314
[TBL] [Abstract][Full Text] [Related]
22. Paradoxical coupling of triglyceride synthesis and fatty acid oxidation in skeletal muscle overexpressing DGAT1.
Liu L; Shi X; Choi CS; Shulman GI; Klaus K; Nair KS; Schwartz GJ; Zhang Y; Goldberg IJ; Yu YH
Diabetes; 2009 Nov; 58(11):2516-24. PubMed ID: 19675136
[TBL] [Abstract][Full Text] [Related]
23. Novel role of a triglyceride-synthesizing enzyme: DGAT1 at the crossroad between triglyceride and cholesterol metabolism.
Sachdev V; Leopold C; Bauer R; Patankar JV; Iqbal J; Obrowsky S; Boverhof R; Doktorova M; Scheicher B; Goeritzer M; Kolb D; Turnbull AV; Zimmer A; Hoefler G; Hussain MM; Groen AK; Kratky D
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1132-1141. PubMed ID: 27344248
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology.
Amin NB; Saxena AR; Somayaji V; Dullea R
Clin Ther; 2023 Jan; 45(1):55-70. PubMed ID: 36690550
[TBL] [Abstract][Full Text] [Related]
25. Dietary Macronutrient Composition Determines the Contribution of DGAT1 to Alcoholic Steatosis.
Huang LS; Yuen JJ; Trites MJ; Saha A; Epps CT; Hu Y; Kerolle S; Lee SA; Jiang H; Goldberg IJ; Blaner WS; Clugston RD
Alcohol Clin Exp Res; 2018 Dec; 42(12):2298-2312. PubMed ID: 30192394
[TBL] [Abstract][Full Text] [Related]
26. Treatment of human skeletal muscle cells with inhibitors of diacylglycerol acyltransferases 1 and 2 to explore isozyme-specific roles on lipid metabolism.
Løvsletten NG; Vu H; Skagen C; Lund J; Kase ET; Thoresen GH; Zammit VA; Rustan AC
Sci Rep; 2020 Jan; 10(1):238. PubMed ID: 31937853
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
[TBL] [Abstract][Full Text] [Related]
28. A novel coenzyme A:diacylglycerol acyltransferase 1 inhibitor stimulates lipid metabolism in muscle and lowers weight in animal models of obesity.
Yamamoto T; Yamaguchi H; Miki H; Kitamura S; Nakada Y; Aicher TD; Pratt SA; Kato K
Eur J Pharmacol; 2011 Jan; 650(2-3):663-72. PubMed ID: 21034741
[TBL] [Abstract][Full Text] [Related]
29. Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production.
Millar JS; Stone SJ; Tietge UJ; Tow B; Billheimer JT; Wong JS; Hamilton RL; Farese RV; Rader DJ
J Lipid Res; 2006 Oct; 47(10):2297-305. PubMed ID: 16877777
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids.
Turner N; Hariharan K; TidAng J; Frangioudakis G; Beale SM; Wright LE; Zeng XY; Leslie SJ; Li JY; Kraegen EW; Cooney GJ; Ye JM
Diabetes; 2009 Nov; 58(11):2547-54. PubMed ID: 19720794
[TBL] [Abstract][Full Text] [Related]
31. Diacylglycerol acyltransferase-1 inhibition enhances intestinal fatty acid oxidation and reduces energy intake in rats.
Schober G; Arnold M; Birtles S; Buckett LK; Pacheco-López G; Turnbull AV; Langhans W; Mansouri A
J Lipid Res; 2013 May; 54(5):1369-84. PubMed ID: 23449193
[TBL] [Abstract][Full Text] [Related]
32. A reconfigured Kennedy pathway which promotes efficient accumulation of medium-chain fatty acids in leaf oils.
Reynolds KB; Taylor MC; Cullerne DP; Blanchard CL; Wood CC; Singh SP; Petrie JR
Plant Biotechnol J; 2017 Nov; 15(11):1397-1408. PubMed ID: 28301719
[TBL] [Abstract][Full Text] [Related]
33. DGAT2 Inhibition Alters Aspects of Triglyceride Metabolism in Rodents but Not in Non-human Primates.
McLaren DG; Han S; Murphy BA; Wilsie L; Stout SJ; Zhou H; Roddy TP; Gorski JN; Metzger DE; Shin MK; Reilly DF; Zhou HH; Tadin-Strapps M; Bartz SR; Cumiskey AM; Graham TH; Shen DM; Akinsanya KO; Previs SF; Imbriglio JE; Pinto S
Cell Metab; 2018 Jun; 27(6):1236-1248.e6. PubMed ID: 29706567
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release--potential insight into mechanism of action.
Liu J; Gorski JN; Gold SJ; Chen D; Chen S; Forrest G; Itoh Y; Marsh DJ; McLaren DG; Shen Z; Sonatore L; Carballo-Jane E; Craw S; Guan X; Karanam B; Sakaki J; Szeto D; Tong X; Xiao J; Yoshimoto R; Yu H; Roddy TP; Balkovec J; Pinto S
Obesity (Silver Spring); 2013 Jul; 21(7):1406-15. PubMed ID: 23671037
[TBL] [Abstract][Full Text] [Related]
35. Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying.
Ables GP; Yang KJ; Vogel S; Hernandez-Ono A; Yu S; Yuen JJ; Birtles S; Buckett LK; Turnbull AV; Goldberg IJ; Blaner WS; Huang LS; Ginsberg HN
J Lipid Res; 2012 Nov; 53(11):2364-79. PubMed ID: 22911105
[TBL] [Abstract][Full Text] [Related]
36. Difference in hepatic metabolism of long- and medium-chain fatty acids: the role of fatty acid chain length in the production of the alcoholic fatty liver.
Lieber CS; Lefèvre A; Spritz N; Feinman L; DeCarli LM
J Clin Invest; 1967 Sep; 46(9):1451-60. PubMed ID: 6036539
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of fatty acids on glucose-regulated B-cell function: association with increased islet triglyceride stores and altered effect of fatty acid oxidation on glucose metabolism.
Zhou YP; Ling ZC; Grill VE
Metabolism; 1996 Aug; 45(8):981-6. PubMed ID: 8769356
[TBL] [Abstract][Full Text] [Related]
38. Dictyostelium discoideum Dgat2 can substitute for the essential function of Dgat1 in triglyceride production but not in ether lipid synthesis.
Du X; Herrfurth C; Gottlieb T; Kawelke S; Feussner K; Rühling H; Feussner I; Maniak M
Eukaryot Cell; 2014 Apr; 13(4):517-26. PubMed ID: 24562909
[TBL] [Abstract][Full Text] [Related]
39. Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2.
Irshad Z; Chmel N; Adya R; Zammit VA
J Lipid Res; 2019 Jan; 60(1):111-120. PubMed ID: 30397187
[TBL] [Abstract][Full Text] [Related]
40. Effect of cholesterol on lipogenesis and VLDL-TG assembly and secretion in goose primary hepatocytes.
Han CC; Wang JW; Pan ZX; Tang H; Xiang SX; Wang J; Li L; Xu F; Wei SH
Mol Cell Biochem; 2013 Feb; 374(1-2):163-72. PubMed ID: 23180245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
